Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye ultrasound could spot hidden artery disease

NCT ID NCT07001059

Diagnosis Sponsor: Hôpital NOVO Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether measuring the optic nerve sheath with ultrasound can reliably diagnose giant cell arteritis (GCA), a condition that can cause blindness. Researchers will enroll 190 people over 50 with suspected GCA and compare ultrasound results to the final diagnosis after 6 months. If the method works, it could offer a quicker, safer way to detect the disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
orbital ultrasound
What this could lead to
If successful, this could provide a faster, non-invasive way to diagnose giant cell arteritis, potentially preventing vision loss.
What could go wrong
This is an early diagnostic study, not a treatment trial. The ultrasound method may not prove reliable enough to replace current diagnostic approaches.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 190 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with suspected GCA * Patient over 50 years Exclusion Criteria: * Patient with history of GCA * Patient with a history of polymyalgia rheumatic (PMR) without initial PET scan * Patient with a history of retinal disease, demyelinating disease, or intracranial hypertension * Use of corticosteroids \> 0.5mg/kg in the last 2 weeks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Giant cell arteritis (GCA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Giant Cell Arteritis temporal arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Giant cell arteritis (GCA)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Internal Medecine Department- CHU Caen

    RECRUITING

    Caen, France

  • Internal Medicine and Clinical Immulogy department - Centre Hospitalier Universitaire de Dijon

    NOT_YET_RECRUITING

    Dijon, France

  • Internal Medicine and VascularMedecine Department - Centre Hospitalier Universitaire de Nantes

    NOT_YET_RECRUITING

    Nantes, France

  • Internal Medicine department - Hôpital Saint-Antoine

    NOT_YET_RECRUITING

    Paris, France

  • Rhumatology departement - Centre Hospitalier Aix en Provence

    NOT_YET_RECRUITING

    Aix-en-Provence, France

  • Rhumatology department - Centre Hospitalier Universitaire de Brest

    NOT_YET_RECRUITING

    Brest, France

  • Rhumatology department - Centre Hospitalier Universitaire de Tours

    NOT_YET_RECRUITING

    Tours, France

  • Rhumatology department - Hôpital Bichat

    NOT_YET_RECRUITING

    Paris, France

  • Rhumatology department - Hôpital NOVO - Pontoise site

    NOT_YET_RECRUITING

    Pontoise, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.